Stick2PrEP Cisgender Women and Trans Individuals

Conditions

• HIV Prevention
• Pre-exposure Prophylaxis

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Accepted

Interventions

• Individualized Feedback — BEHAVIORAL
  Participants taking PrEP will receive questionnaires regarding self-reported weekly PrEP adherence; they will then receive individualized text-message or email feedback based on their self-reported adherence.

Study Details

Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preferences about HIV prevention options, especially as new options become available. This study plans to evaluate preferences over time among cisgender women and trans individuals who are taking medication to prevent HIV, and among cisgender women and trans individuals who are not taking medication but are at risk of HIV. The investigators enroll up to 175 participants who visit the HIV prevention clinic, and the investigators will ask participants to complete questionnaires at regular follow up visits and between visits. This study may help the investigators understand how best to prevent HIV among people at risk.

Key Dates

Start date

Oct 25, 2021

Status verified

Aug 2025

Primary completion

Oct 25, 2026

Completion

Oct 25, 2026

Study Design

Enrollment

175 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Arms

• Other: Cisgender Women and Trans Individuals (CWTI)
  Cisgender women and trans individuals (CWTI) who are taking PrEP, have considered and decided not to take PrEP, or who have discontinued PrEP.

Primary Outcome Measure

Correlation Between PrEP modality preference and PrEP initiation/persistence in care [ Time Frame: 12 months ]

Central Contacts

• Deborah Theodore, MD
  2123052201
  [email protected]

Locations (1)

Find similar trials in New York, NY

Related Studies

• Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM
  Not Yet Recruiting · Yale University · New York, New York
• Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional Stigma
  Not Yet Recruiting · NYU Langone Health · New York, New York
• A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
  Not Yet Recruiting · NYU Langone Health · Los Angeles, California
• Examining Migration, Social Bonds, Transnationalism, and HIV Prevention Pathways Among African Immigrants.
  Not Yet Recruiting · State University of New York at Buffalo · Buffalo, New York